Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lymphoma
Pharma
Inconsistent survival data dent Roche's Columvi win in 2L DLBCL
An exploratory analysis showed that Columvi’s overall survival benefit appeared to be driven entirely by patients outside the U.S. and Europe.
Angus Liu
Jun 16, 2024 5:32pm
Brazil taps nonprofit to slash cell therapy production costs
Mar 26, 2024 8:44am
Jazz secures FDA nod for revised blood cancer dosing schedule
Nov 22, 2022 10:30am
NICE signs off on BeiGene's Brukinsa for blood cancer disorder
Sep 20, 2022 10:10am
Novartis' Kymriah faces off against Yescarta with new nod
May 31, 2022 8:04am
A new complaint emerges in BMS' contingent value rights lawsuit
Feb 23, 2022 1:10pm
